Self-screening for Atrial Fibrillation using ECG monitoring
The NORwegian Atrial Fibrillation Self-SCREENing
This study is testing if using a special ECG patch at home can help older adults at risk for stroke find out if they have atrial fibrillation earlier and manage it better.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 35000 (estimated) |
| Ages | 65 Years and up |
| Sex | All |
| Sponsor | Oslo University Hospital Academic / other |
| Locations | 1 site (Oslo) |
| Trial ID | NCT05914883 on ClinicalTrials.gov |
What this trial studies
This clinical trial aims to evaluate the effectiveness of self-screening for atrial fibrillation (AF) using the ECG247 patch monitor. It focuses on older adults who are at risk for stroke, assessing whether long-term continuous ECG monitoring can reduce morbidity associated with undiagnosed AF. The study will involve randomized participants who meet specific age and risk factor criteria, while excluding those with a history of AF or certain medical devices. The goal is to improve early detection and management of AF in the community.
Who should consider this trial
Good fit: Ideal candidates are individuals aged 65 and older with at least one additional stroke risk factor.
Not a fit: Patients with a history of atrial fibrillation or those currently using anticoagulation therapy will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to earlier diagnosis and reduced complications from atrial fibrillation for patients.
How similar studies have performed: Other studies have shown promise in using self-monitoring technologies for AF detection, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥65 years and minimum one other risk factor for stroke according to the CHA2DS2-VASc risk score: Age ≥75 years, Diabetes, Heart failure, Hypertension, Previous stroke/TIA and/or Vascular disease * Informed consent for participation Exclusion Criteria: * History of AF (self-reported) * Use of anticoagulation therapy * Pacemaker/CRT device * No smart phone
Where this trial is running
Oslo
- Oslo Unvirsity Hospital — Oslo, Norway (Recruiting)
Study contacts
- Study coordinator: Sigrun Halvorsen, MD, PhD
- Email: sigruha@uio.no
- Phone: +4791317460
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.